The National Coalition on Health Care (NCHC) opposes the Administration’s approach to address drug pricing through the “Most-Favored-Nation” (MFN) executive order released yesterday. The executive order rightly recognizes the urgency of addressing exorbitant drug prices, for the sake of the Medicare program and for its beneficiaries, but we encourage the White House to apply this […]
The Path Forward: The 2020 Elections and Re-Imagining the Health Care System Amid Crisis
On October 1, NCHC will host a virtual event bringing together expert perspectives on the Trump and Biden presidential campaigns to share the candidates’ plan to reinvent our nation’s health care system for our patients, providers, and communities. The conversation will be moderated by Noam Levey, a national health care reporter with the Los Angeles Times, followed […]
NCHC: Drug Pricing Primer
High prescription drug prices contribute to high total health care costs in the United States. Prices in the United States are higher than any other developed country, outpacing the effects of volume, types of drugs, or population size on total drug spending. Retail prescription drugs accounted for 9% of the $3.6 trillion (17.7% of GDP) […]
Another Looming Catastrophe: The Lawsuit Against the Affordable Care Act
The Administration’s continued pursuit to strike down the Affordable Care Act (ACA) in the courts openly undermines affordable health insurance coverage during the pandemic, threatening our public health response and economic recovery. The COVID-19 pandemic has caused unprecedented and widespread damage to our health and economy Since January, more than 3 million people have been […]
NCHC Statement on the Pricing of Remdesivir
On Monday, June 29, Gilead announced the pricing of remdesivir, an anti-viral drug that treats COVID-19. The Coalition supports protecting consumers from unaffordable drug costs. The pricing decision will exacerbate the health care affordability crisis already plaguing the country’s response to COVID-19. Fundamentally, the United States needs to develop a fair drug pricing system that […]
- 1
- 2
- 3
- …
- 9
- Next Page »